Table 3 Significant association between miRNAs at 3Â h and rivaroxaban PK-PD profiles
Group criteria | Fasted | FCcase–control | p value | Fed | FCcase–control | p | Total | FCcase–control | p value |
|---|---|---|---|---|---|---|---|---|---|
15Â mg | |||||||||
Grouped by AXA3h | |||||||||
 3 h: case vs control | miR-483↑ | 3.38 | 0.0111 | – | – | – | miR-483↑ | 2.44 | 0.0310 |
Grouped by AUC0-t | |||||||||
 3 h: case vs control | miR-483↑ | 3.12 | 0.0379 | – | – | – | miR-483↑ | 2.21 | 0.0067 |
10Â mg | |||||||||
Grouped by AXA3h | |||||||||
 3 h: case vs control | – | – | – | miR-483↑ | 213.95 | 0.0317 | – | – | – |
Grouped by AUC0-t | |||||||||
 3 h: case vs control | – | – | – | miR-320a↑ | 35.89 | 0.0317 | – | – | – |
 3 h: case vs control | – | – | – | miR-483↑ | 191.69 | 0.0159 | – | – | – |